High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer.

Asmus HeumannNina HeinemannClaudia Hube-MaggDagmar S LangKatharina GruppMartina KluthSarah MinnerChristina Möller-KoopMarkus GraefenHans HeinzerMaria Christina TsourlakisWaldemar WilczakCorinna WittmerFrank JacobsenHartwig HulandRonald SimonThorsten SchlommGuido SauterStefan SteurerPatrick LebokAndrea Hinsch

Published in: BMC cancer (2018)

The results of our study identify BCAR1 as a prognostic biomarker with potential clinical value for risk stratification of ERG-negative prostate cancer.

Keyphrases

prostate cancer
radical prostatectomy
poor prognosis
binding protein
human health